MPO and acute promyelocytic leukemia: After immunohistochemical staining, 98.1 ± 3.5 % of APL blasts resulted MPO-positive at baseline, compared to 58 ± 28.2% of AML and 47.6 ± 26.3% of HS-AML samples.